Cargando…

Biological Aggressiveness of Subclinical No-Mass Ductal Carcinoma In Situ (DCIS) Can Be Reflected by the Expression Profiles of Epithelial-Mesenchymal Transition Triggers

Epithelial-mesenchymal transitions (EMTs) have been recently implicated in the process of cancer progression. The aim of this study was to assess how the preoperative expression patterns of EMT biomarkers correlate with the risk of postoperative invasion in ductal carcinoma in situ (DCIS) found on s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szynglarewicz, Bartlomiej, Kasprzak, Piotr, Donizy, Piotr, Biecek, Przemyslaw, Halon, Agnieszka, Matkowski, Rafal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320898/ https://www.ncbi.nlm.nih.gov/pubmed/30544617 http://dx.doi.org/10.3390/ijms19123941

Ejemplares similares

Screen-detected ductal carcinoma in situ found on stereotactic vacuum-assisted biopsy of suspicious microcalcifications without mass: radiological-histological correlation
por: Szynglarewicz, Bartlomiej, et al.
Publicado: (2016)

Preoperatively diagnosed ductal cancers in situ of the breast presenting as even small masses are of high risk for the invasive cancer foci in postoperative specimen
por: Szynglarewicz, Bartlomiej, et al.
Publicado: (2015)

Lobular carcinoma in situ of the breast – correlation between minimally invasive biopsy and final pathology
por: Szynglarewicz, Bartłomiej, et al.
Publicado: (2016)

Nucleoli cytomorphology in cutaneous melanoma cells – a new prognostic approach to an old concept
por: Donizy, Piotr, et al.
Publicado: (2017)

Golgi-Related Proteins GOLPH2 (GP73/GOLM1) and GOLPH3 (GOPP1/MIDAS) in Cutaneous Melanoma: Patterns of Expression and Prognostic Significance
por: Donizy, Piotr, et al.
Publicado: (2016)

ERM/Rho protein expression in ductal breast cancer: a 15 year follow-up
por: Halon, Agnieszka, et al.
Publicado: (2013)

HER-2 Expression in Immunohistochemistry Has No Prognostic Significance in Gastric Cancer Patients
por: Halon, Agnieszka, et al.
Publicado: (2012)

The use of ultrasonic scalpel lowers the risk of post-mastectomy seroma formation in obese women
por: Michalik, Tomasz, et al.
Publicado: (2019)

Breast segmentectomy with rotation mammoplasty as an oncoplastic approach to extensive ductal carcinoma in situ
por: Szynglarewicz, Bartlomiej, et al.
Publicado: (2016)

Ultralow Anterior Resection with Implantation of Gentamicin-collagen Sponge and No Defunctioning Stoma: Anastomotic Leakage and Local Cancer Relapse
por: Michalik, Tomasz, et al.
Publicado: (2019)

Assessment of Ki-67 proliferation index with deep learning in DCIS (ductal carcinoma in situ)
por: Fulawka, Lukasz, et al.
Publicado: (2022)

High Percentage of ADAM-10 Positive Melanoma Cells Correlates with Paucity of Tumor-Infiltrating Lymphocytes but Does Not Predict Prognosis in Cutaneous Melanoma Patients
por: Donizy, Piotr, et al.
Publicado: (2015)

Ductal carcinoma in situ (DCIS)
por: Holland, R
Publicado: (2002)

Prognostic significance of ALCAM (CD166/MEMD) expression in cutaneous melanoma patients
por: Donizy, Piotr, et al.
Publicado: (2015)

Augmented expression of Polo-like kinase 1 is a strong predictor of shorter cancer-specific overall survival in early stage breast cancer at 15-year follow-up
por: Donizy, Piotr, et al.
Publicado: (2016)

Ductal carcinoma in situ (DCIS): are we overdetecting it?
por: Evans, A
Publicado: (2004)

Ductal carcinoma in situ (DCIS): are we overtreating it?
por: Dixon, JM
Publicado: (2004)

Educational Case: Ductal Carcinoma In Situ (DCIS)
por: Komforti, Miglena K., et al.
Publicado: (2019)

MRP2 (ABCC2, cMOAT) expression in nuclear envelope of primary fallopian tube cancer cells is a new unfavorable prognostic factor
por: Halon, Agnieszka, et al.
Publicado: (2012)

Upregulation of FOXP1 is a new independent unfavorable prognosticator and a specific predictor of lymphatic dissemination in cutaneous melanoma patients
por: Donizy, Piotr, et al.
Publicado: (2018)

Ductal Carcinoma In Situ (DCIS) and Microinvasive DCIS: Role of Surgery in Early Diagnosis of Breast Cancer
por: Magnoni, Francesca, et al.
Publicado: (2023)

Clinicopathological characteristics and prognostic analysis of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ (DCIS) and DCIS with microinvasion (DCIS-Mi) of the breast
por: Jia, Huiqing, et al.
Publicado: (2022)

Epidemiology, Biology, Treatment, and Prevention of Ductal Carcinoma In Situ (DCIS)
por: Punglia, Rinaa S, et al.
Publicado: (2018)

Grading Ductal Carcinoma In Situ (DCIS) of the Breast – What’s Wrong with It?
por: Cserni, Gábor, et al.
Publicado: (2019)

Multimodality imaging in lobular breast cancer: Differences in mammography, ultrasound, and MRI in the assessment of local tumor extent and correlation with molecular characteristics
por: Dołęga-Kozierowski, Bartosz, et al.
Publicado: (2022)

Vascular density and phenotype around ductal carcinoma in situ (DCIS) of the breast
por: Teo, N B, et al.
Publicado: (2002)

Paget's disease of the male breast with underlying ductal carcinoma in situ (‘DCIS’)
por: Choudhury, Bhuban, et al.
Publicado: (2015)

Multi-protein spatial signatures in ductal carcinoma in situ (DCIS) of breast
por: Badve, Sunil S., et al.
Publicado: (2021)

Tissue laser biostimulation promotes post-extraction neoangiogenesis in HIV-infected patients
por: Halon, Agnieszka, et al.
Publicado: (2013)

Cancer stem cells – the current status of an old concept: literature review and clinical approaches
por: Fulawka, Lukasz, et al.
Publicado: (2014)

Is palpable DCIS more aggressive than screen-detected DCIS?
por: Balac, Nina, et al.
Publicado: (2022)

The Emerging Roles of Steroid Hormone Receptors in Ductal Carcinoma in Situ (DCIS) of the Breast
por: Villanueva, Hugo, et al.
Publicado: (2018)

Improving Therapeutic Ratios with the Oncotype DX® Ductal Carcinoma In Situ (DCIS) Score
por: Lalani, Nafisha, et al.
Publicado: (2017)

Effect of Quantitative Nuclear Image Features on Recurrence of Ductal Carcinoma In Situ (DCIS) of the Breast
por: Axelrod, David E., et al.
Publicado: (2008)

Trends and predictors of size and grade for ductal carcinoma in situ (DCIS) in BreastScreen Victoria
por: Erbas, B, et al.
Publicado: (2004)

Challenging paradigms: long non-coding RNAs in breast ductal carcinoma in situ (DCIS)
por: Kosir, Mary A., et al.
Publicado: (2013)

Tumor Infiltrating Lymphocytes in Multi-National Cohorts of Ductal Carcinoma In Situ (DCIS) of Breast
por: Badve, Sunil S., et al.
Publicado: (2022)

The natural history of ductal carcinoma in situ (DCIS) in simulation models: A systematic review
por: Poelhekken, Keris, et al.
Publicado: (2023)

Molecular Signatures in Ductal Carcinoma In Situ (DCIS): A Systematic Review and Meta-Analysis
por: Ouattara, Drissa, et al.
Publicado: (2023)

Levels of miR-126 and miR-218 are elevated in ductal carcinoma in situ (DCIS) and inhibit malignant potential of DCIS derived cells
por: Volinia, Stefano, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5u6ukjs06asb7dsv3i7i18um5o